Cost-Effectiveness of ^sup 99m^Tc-Sestamibi in Predicting Response to Chemotherapy in Patients with Lung Cancer: Systematic Review and Meta-Analysis

Multidrug resistance (MDR) is a major problem in lung cancer. ^sup 99m^Tc-methoxyisobutylisonitrile (^sup 99m^Tc-MIBI) has been demonstrated to be a noninvasive marker for the diagnosis of MDR-related P glycoprotein and MDR-associated protein expression in various solid tumors. Studies have shown th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of nuclear medicine (1978) 2009-03, Vol.50 (3), p.376
Hauptverfasser:	Mohan, Hosahalli K, Miles, Kenneth A
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Health care policy Lung cancer Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!